A multiomic study describes, for the first time, the accumulation of genetic alterations that dictate the malignancy of a type of thyroid tumour, more prevalent in children and young adults.
Read moreThe biotech company GAT Therapeutics is making progress in the development of GTX-11, a new oral drug candidate for the treatment of idiopathic pulmonary fibrosis. Preclinical results show that GTX-11...
Read moreLos adultos mayores en los que esta bacteria estaba presente presentaban un 29% más de fuerza de prensión manual en comparación con aquellos en los que no se detectaba. En los adultos jóvenes, una...
Read moreThe research focuses on a protein called "Slowpoke" that promotes communication between neurons and the tumour
Read moreUnlike current drugs, which mainly remove beta-amyloid plaques that accumulate in the brain, this new experimental drug reprogrammes the neuronal epigenome by correcting alterations in gene expression...
Read moreEl consumo excesivo de alcohol, tanto crónico como ocasional, provoca alteraciones en la glucólisis, la principal vía metabólica para producir energía, lo que podría sugerir una conexión entre ...
Read moreEl trabajo, coliderado por la Universidad Autónoma de Madrid, está centrado en un plásmido de gran interés clínico porque está asociado a bacterias resistentes a los carbapenémicos, antibiótic...
Read moreEl hallazgo abre la puerta al desarrollo de nuevas terapias para abordar las alteraciones puberales vinculadas al exceso de peso en la infancia.
Read moreWorking memory is a cognitive function that is essential for carrying out everyday activities and temporarily retaining information. This process enables us to understand information, learn and manage...
Read moreResearch highlights that the loss of genetic material influences the age at which the disorder first appears
Read moreResearchers at the University of Navarra are participating in the development a biomarker that, based on brain electrical activity and artificial intelligence, is capable of identifying the risk of fu...
Read moreJoan Perelló and Arturo Urrios will lead a new vertical focused on company creation and early-stage biotech projects, with a strong focus on Spain.
Read more